CLVR
- Clever Leaves Holdings Inc.
()
Overview
Company Summary
Clever Leaves Holdings Inc. (CLVR) is a company specializing in the production and distribution of pharmaceutical-grade medical cannabis. They operate globally and focus on cultivating high-quality cannabis plants for the extraction of active pharmaceutical ingredients (APIs).
One of Clever Leaves' primary activities is the development of cannabis strains with specific chemical compositions, such as different ratios of cannabinoids like THC (tetrahydrocannabinol) and CBD (cannabidiol). Clever Leaves utilizes advanced cultivation techniques to optimize the growth and potency of their cannabis plants, ensuring consistent, standardized, and reliable products.
In addition to cultivation, Clever Leaves also engages in extraction processes to obtain the valuable APIs from the cannabis plant. These APIs are used in the formulation of various medical cannabis products, including oils, tinctures, capsules, and topicals. Clever Leaves focuses on following strict pharmaceutical standards, ensuring quality, safety, and traceability throughout the production process.
Furthermore, Clever Leaves operates in the business-to-business (B2B) sector, working with partners such as pharmaceutical companies and licensed distributors. They supply their products both domestically and internationally, contributing to the expanding global cannabis market. Clever Leaves' reach extends to countries where medical cannabis is legal, allowing them to address the growing demand for alternative medical treatments.
Overall, Clever Leaves Holdings Inc. plays a crucial role in the medical cannabis industry, focusing on the cultivation, extraction, and distribution of pharmaceutical-grade cannabis products, all while adhering to stringent quality standards.